Martin D. Burke
39Patents
3h-index
50Co-inventors
62Inventor score
Filing activity: Nov 8, 2007 → Sep 20, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8338601B2 | Slow release of organoboronic acids in cross-coupling reactions | Emerging Cross-Sectional Technologies | 9 | Active |
| US8013203B2 | System for controlling the reactivity of boronic acids | Emerging Cross-Sectional Technologies | 8 | Active |
| US9957290B2 | Derivatives of amphotericin B | Human Necessities | 6 | Active |
| US10597420B2 | Derivatives of amphotericin B | Human Necessities | 3 | Active |
| US8318983B2 | System for controlling the reactivity of boronic acids | Emerging Cross-Sectional Technologies | 3 | Active |
| US10323057B2 | Amphotericin B derivatives with improved therapeutic index | Human Necessities | 3 | Active |
| US9738677B2 | Amphotericin B derivative with reduced toxicity | Human Necessities | 2 | Active |
| US9238597B2 | Apparatus and methods for the automated synthesis of small molecules | Emerging Cross-Sectional Technologies | 2 | Active |
| US9006463B2 | Slow release of organoboronic acids in cross-coupling reactions | Emerging Cross-Sectional Technologies | 2 | Active |
| US8754251B2 | Cyclopropyl PIDA boronate | Emerging Cross-Sectional Technologies | 2 | Active |
| US10087206B2 | Scalable synthesis of reduced toxicity derivative of amphotericin B | Chemistry; Metallurgy | 1 | Active |
| US11850256B2 | Small molecule-mediated restoration of airway surface physiology in human cystic fibrosis lung epithelia | Chemistry; Metallurgy | 1 | Active |
| US9328102B2 | Slow release of organoboronic acids in cross-coupling reactions | Emerging Cross-Sectional Technologies | 1 | Active |
| US10882883B2 | Derivatives of amphotericin B | Human Necessities | 1 | Active |
| US10239824B2 | Automated synthesis of small molecules using chiral, non-racemic boronates | Chemistry; Metallurgy | 1 | Active |
| US11028114B2 | Amphotericin B derivatives with improved therapeutic index | Human Necessities | 1 | Active |
| US12090164B2 | Genotype-agnostic rescue of cystic fibrosis with small molecule bicarbonate channels | Human Necessities | 1 | Active |
| US8557980B2 | Methods for forming protected organoboronic acids | Chemistry; Metallurgy | 1 | Active |
| US11117920B2 | Amphotericin B derivatives with improved therapeutic index | Human Necessities | 1 | Active |
| US11517540B2 | Restoring physiology in iron-deficient organisms using small molecules | Physics | 0 | Active |
| US9388131B2 | Automated synthesis of small molecules using chiral, non-racemic boronates | Chemistry; Metallurgy | 0 | Active |
| US9732102B2 | System for controlling the reactivity of boronic acids | Emerging Cross-Sectional Technologies | 0 | Active |
| US10844081B2 | Protected organoboronic acids with tunable reactivity, and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US10683318B2 | Scalable synthesis of reduced toxicity derivative of amphotericin B | Chemistry; Metallurgy | 0 | Active |
| US10370393B2 | Stereoretentive cross-coupling of boronic acids | Performing Operations; Transporting | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.